US 8431615
Dose forms
granted A61KA61K31/454A61K31/7056
Quick answer
US patent 8431615 (Dose forms) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/454, A61K31/7056, A61K38/21, A61K38/212